Understanding how bacteria adapt to resist medicines
Bacterial ribosome heterogeneity and gene expression
This research looks at how bacteria change their internal machinery to find new ways to create medicines that can fight infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11128678 on NIH RePORTER |
What this research studies
Antibiotic resistance is a growing problem, making it harder to treat bacterial infections around the world. This research aims to discover new ways to develop medicines by understanding how bacteria control their genes and produce harmful substances. Scientists are focusing on tiny parts of bacteria called ribosomes, which are like factories that make proteins, and how variations in these ribosomes can change how bacteria behave. By learning more about these changes, we hope to find new weak spots in bacteria that future drugs can target.
Who could benefit from this research
Good fit: This foundational research does not directly involve patients, but future clinical trials stemming from this work would seek individuals with specific bacterial infections.
Not a fit: Patients not currently suffering from bacterial infections or those whose infections are treatable with existing antibiotics may not directly benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new targets for developing much-needed antibiotics to combat resistant bacterial infections.
How similar studies have performed: This work builds on the lab's previous discovery of a specific ribosomal protein affecting bacterial virulence, suggesting a novel approach to understanding gene expression and drug targets.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Ramsey, Kathryn Mary — University of Louisville
- Study coordinator: Ramsey, Kathryn Mary
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.